Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
Scientific Programming ; : 1-10, 2021.
Article in English | Academic Search Complete | ID: covidwho-1201835

ABSTRACT

The novel coronavirus (COVID-19) outbreak produced devastating effects on the global economy and the health of entire communities. Although the COVID-19 survival rate is high, the number of severe cases that result in death is increasing daily. A timely prediction of at-risk patients of COVID-19 with precautionary measures is expected to increase the survival rate of patients and reduce the fatality rate. This research provides a prediction method for the early identification of COVID-19 patient's outcome based on patients' characteristics monitored at home, while in quarantine. The study was performed using 287 COVID-19 samples of patients from the King Fahad University Hospital, Saudi Arabia. The data were analyzed using three classification algorithms, namely, logistic regression (LR), random forest (RF), and extreme gradient boosting (XGB). Initially, the data were preprocessed using several preprocessing techniques. Furthermore, 10-k cross-validation was applied for data partitioning and SMOTE for alleviating the data imbalance. Experiments were performed using twenty clinical features, identified as significant for predicting the survival versus the deceased COVID-19 patients. The results showed that RF outperformed the other classifiers with an accuracy of 0.95 and area under curve (AUC) of 0.99. The proposed model can assist the decision-making and health care professional by early identification of at-risk COVID-19 patients effectively. [ABSTRACT FROM AUTHOR] Copyright of Scientific Programming is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

2.
Saudi Med J ; 41(8): 779-790, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-918553

ABSTRACT

[No Abstract Available]    Saudi Med J 2020; Vol. 41 (8): 779-790doi: 10.15537/smj.2020.8.25222 How to cite this article:Yaser A. Faden, Nadia A. Alghilan,  Samiha H. Alawami, Eman S. Alsulmi, Hythem A. Alsum, Yasir A. Katib, Yasser S. Sabr, Fadwah H. Tahir, Nabeel S. Bondagji. Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019. Saudi Med J 2020; Vol. 41 (8): 779-790. doi: 10.15537/smj.2020.8.25222.


Subject(s)
Coronavirus Infections/therapy , Pneumonia, Viral/therapy , Pregnancy Complications, Infectious/therapy , Prenatal Care/methods , Anticoagulants/therapeutic use , Antiviral Agents/therapeutic use , Betacoronavirus , COVID-19 , Congenital Abnormalities/virology , Coronavirus Infections/drug therapy , Coronavirus Infections/transmission , Critical Illness , Delivery, Obstetric/methods , Female , Heparin/therapeutic use , Humans , Hydroxychloroquine/therapeutic use , Infant, Newborn , Infectious Disease Transmission, Vertical , Magnesium Sulfate/therapeutic use , Pandemics , Perinatology , Personal Protective Equipment , Pneumonia, Viral/transmission , Postnatal Care , Pregnancy , Pregnancy Outcome , SARS-CoV-2 , Saudi Arabia , Societies, Medical , Thromboembolism/prevention & control , Tocolytic Agents/therapeutic use , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL